ReviewBioengineered2019
Bioengineering tools for the production of pharmaceuticals: current perspective and future outlook.
Review in Bioengineered, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Applications of Recombinant DNA Technology in Medicine: A Comprehensive Review.Molecular biotechnology · 2026Review
- Effect of Silica Xerogel Functionalization on Intensification ofLife (Basel, Switzerland) · 2024Article
- Treatment with FAP-targeted zinc ferrite nanoparticles for rheumatoid arthritis by inducing endoplasmic reticulum stress and mitochondrial damage.Materials today. Bio · 2023Article
- Developing biomedical engineering technologies for reproductive medicine.Smart medicine · 2022Review
- Selective Impact of MTMS-Based Xerogel Morphology on Boosted Proliferation and Enhanced Naphthoquinone Production in Cultures ofInternational journal of molecular sciences · 2022Article
- Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer.Bioengineered · 2022Article
- Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection.Bioengineered · 2022Review
- Overhauling the Effect of Surface Sterilization on Analysis of Endophytes in Tea Plants.Frontiers in plant science · 2022Article
- Changes in global Orchidaceae disease geographical research trends: recent incidences, distributions, treatment, and challenges.Bioengineered · 2021Review
- Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.Microbial cell factories · 2021Review
- Comparative Transcriptome Analysis of Genes Involved in Sesquiterpene Alkaloid Biosynthesis inFrontiers in microbiology · 2021Article
- Rapid propagation in vitro and accumulation of active substances of endangeredBioengineered · 2020Article
- Metagenomics for taxonomy profiling: tools and approaches.Bioengineered · 2020Article
- Implications of endophytic microbiota inBioengineered · 2020Review
- Emerging priorities for microbial metagenome research.Bioresource technology reports · 2020Review
- Molecular Identification of Endophytic Fungi and Their Pathogenicity Evaluation AgainstInternational journal of molecular sciences · 2020Article
- New Insights into Detection of a Dendrobine Compound From a Novel EndophyticFrontiers in microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bioengineering tools have significant advantages through less time-consuming and utilized as a promising stage for the production of pharmaceutical bioproducts under the single platform. This review highlighted the advantages and current improvement in the plant, animal and microbial bioengineering tools and outlines feasible approaches by biological and process's bioengineering levels for advancing the economic feasibility of pharmaceutical's production. The critical analysis results revealed that system biology and synthetic biology along with advanced bioengineering tools like transcriptome, proteome, metabolome and nano bioengineering tools have shown a promising impact on the development of pharmaceutical's bioproducts. Tools to overcome and resolve the accompanying encounters of pharmaceutical's production that include nano bioengineering tools are also discussed. As a summary and prospect, it also gives new insight into the challenges and possible breakthrough of the development of pharmaceutical's bioproducts through bioengineering tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.